Işgör YG - Search Results

1

Evaluation of novel aminomethyl indole derivatives as Src kinase inhibitors and antioxidant agents.

Ölgen S, Kılıç-Kurt Z, Sener F, Işgör YG, Coban T. Ölgen S, et al. Among authors: isgor yg. Chemotherapy. 2011;57(1):1-6. doi: 10.1159/000317764. Epub 2010 Dec 3. Chemotherapy. 2011. PMID: 21124025

2

Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.

Olgen S, Isgör YG, Coban T. Olgen S, et al. Among authors: isgor yg. Arch Pharm (Weinheim). 2008 Feb;341(2):113-20. doi: 10.1002/ardp.200700141. Arch Pharm (Weinheim). 2008. PMID: 18214841

3

Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.

Işgör YG, Kiliç Z, Olgen S. Işgör YG, et al. Chem Biol Drug Des. 2008 Dec;72(6):599-604. doi: 10.1111/j.1747-0285.2008.00734.x. Chem Biol Drug Des. 2008. PMID: 19090928

4

Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.

Kiliç Z, Isgör YG, Olgen S. Kiliç Z, et al. Among authors: isgor yg. Arch Pharm (Weinheim). 2009 Jun;342(6):333-43. doi: 10.1002/ardp.200800216. Arch Pharm (Weinheim). 2009. PMID: 19475593

5

Evaluation of new indole and bromoindole derivatives as pp60(c-Src) tyrosine kinase inhibitors.

Kiliç Z, Işgör YG, Olgen S. Kiliç Z, et al. Among authors: isgor yg. Chem Biol Drug Des. 2009 Oct;74(4):397-404. doi: 10.1111/j.1747-0285.2009.00876.x. Epub 2009 Aug 19. Chem Biol Drug Des. 2009. PMID: 19691468

6

N-substituted indole-3-imine derivatives and their amine congeners: antioxidant and Src kinase inhibitory effects.

Kiliç Z, Sener F, Işgör YG, Coban T, Olgen S. Kiliç Z, et al. Among authors: isgor yg. Z Naturforsch C J Biosci. 2010 May-Jun;65(5-6):347-54. Z Naturforsch C J Biosci. 2010. PMID: 20653236

7

Evaluation of perylenediimide derivatives for potential therapeutic benefits on cancer chemotherapy.

Keskin T, Isgor BS, Isgor YG, Yukruk F. Keskin T, et al. Among authors: isgor yg. Chem Biol Drug Des. 2012 Nov;80(5):675-81. doi: 10.1111/cbdd.12004. Epub 2012 Aug 31. Chem Biol Drug Des. 2012. PMID: 22834711

8

The potential medicinal value of plants from Asteraceae family with antioxidant defense enzymes as biological targets.

Koc S, Isgor BS, Isgor YG, Shomali Moghaddam N, Yildirim O. Koc S, et al. Among authors: isgor yg. Pharm Biol. 2015 May;53(5):746-51. doi: 10.3109/13880209.2014.942788. Epub 2014 Oct 23. Pharm Biol. 2015. PMID: 25339240 Free article.

9

Serum dipeptidylpeptidase activity and tissue polypeptide specific antigen in patients with advanced cirrhosis: preliminary results.

Akbay A, Bozbaş A, Işgör Y, Yavuz Y, Elgün S. Akbay A, et al. Clin Chim Acta. 2000 Feb 25;292(1-2):181-5. doi: 10.1016/s0009-8981(99)00214-4. Clin Chim Acta. 2000. PMID: 10686288 No abstract available.

10

Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.

Glover CJ, Rabow AA, Isgor YG, Shoemaker RH, Covell DG. Glover CJ, et al. Among authors: isgor yg. Biochem Pharmacol. 2007 Feb 1;73(3):331-40. doi: 10.1016/j.bcp.2006.10.005. Epub 2006 Oct 13. Biochem Pharmacol. 2007. PMID: 17109823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters